首页> 美国卫生研究院文献>OncoTargets and therapy >Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis
【2h】

Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis

机译:奇偶性与浸润性乳腺癌临床病理因素的关联:回顾性分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to determine the relationship between parity and age at diagnosis, primary tumor size, axillary lymph node (ALN) metastasis, histological grade, and subtype classification in patients with breast cancer. Data from 392 patients with invasive breast cancer were collected and divided into four groups: nulliparous (parity 0), parity 1, parity 2, and parity ≥3. The relationship between parity and age at diagnosis was assessed using post hoc Dunnett’s T3 test, and tumor size, the number of ALN metastases, and histological grade were analyzed using Spearman’s rho test. Breast cancer subtypes were analyzed using the chi-square (χ2) test. The results showed that the mean age at diagnosis increased with increased parity, and the mean age of patients with parity ≥3 was significantly greater than that of patients with parity 0, parity 1, and parity 2. The mean age at diagnosis of patients with parity 2 was greater than that of patients with parity 1. There was no significant difference in the mean age between patients with parity 0 and parity 1 or parity 0 and parity 2. Parity was negatively correlated with ALN metastasis. Parity was not correlated with tumor size or histological grade and the proportion of the four subtypes in breast cancer. So, increased parity deferred the onset of breast cancer and inhibited the metastasis of ALN, but did not affect tumor size, histological grade, or the proportion of subtypes. Increased parity was a protective factor against breast cancer.
机译:这项研究的目的是确定乳腺癌患者中诊断与均等与年龄,原发肿瘤大小,腋窝淋巴结转移,组织学等级和亚型分类之间的关系。收集了392例浸润性乳腺癌患者的数据,并将其分为四组:未产(胎次为0),胎次为1,胎次为2和胎次≥3。使用事后邓尼特(Dunnett)T3检验评估了诊断中的均等与年龄之间的关系,并使用Spearman的rho检验分析了肿瘤的大小,ALN转移的数量和组织学分级。使用卡方检验(χ 2 )分析乳腺癌亚型。结果显示,随着胎次的增加,诊断的平均年龄增加,胎龄≥3的患者的平均年龄显着大于胎次0,胎次1和胎次2的患者。奇偶校验2大于同等水平1的患者。奇偶校验0和1或奇偶校验0和2的患者的平均年龄无显着差异。奇偶校验与ALN转移呈负相关。奇偶校验与乳腺癌的肿瘤大小或组织学等级以及四种亚型的比例无关。因此,增加胎次可延缓乳腺癌的发作并抑制ALN的转移,但不会影响肿瘤的大小,组织学等级或亚型的比例。平价增加是预防乳腺癌的保护因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号